T1	Participants 13 26	Wilms' tumor.
T2	Participants 48 69	National Wilms' Tumor
T3	Participants 88 109	National Wilms' Tumor
T4	Participants 147 164	low-risk patients
T5	Participants 198 229	those at high risk for relapse.
T6	Participants 230 254	Eligible patients (1439)
T7	Participants 284 423	stage (I-IV) and histology (favorable [FH] or unfavorable [UH]), and contributed data to survival and relapse-free survival (RFS) analyses.
T8	Participants 424 472	Four-year (postnephrectomy) survival percentages
T9	Participants 1049 1067	high-risk patients
